News & Events – Page 2 – www.brainwork.md

25th January 2019

‘Leaky’ blood vessels linked to Alzheimer’s

https://www.brainwork.md/content/uploads/2019/01/luis-tosta-266667-unsplash.jpg 3500 2333 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 25th January 2019 1st February 2019

Leaky blood vessels in the brain appear to be a driver of cognitive dysfunction in Alzheimer’s disease, a new study reports. The research, published in…

Peter Stevenson, PhD
0
1

18th January 2019

Acting fast on atrial fibrillation

https://www.brainwork.md/content/uploads/2019/01/Brainwork-ActingFast.jpg 2800 2100 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 18th January 2019 1st February 2019

Early detection of atrial fibrillation – the next breakthrough in health and wearable technology? Johnson & Johnson, in collaboration with Apple Inc., just announced plans…

Carlotta Foletti, PhD
0
0

30th November 2018

Gene therapy shows promise in Parkinson’s disease

https://www.brainwork.md/content/uploads/2018/11/Brainwork-ParkinsonsPromise.jpg 2100 1400 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 30th November 2018 30th November 2018

Interim results from a Phase Ib trial show that gene therapy may reduce the need for medication in patients with Parkinson’s disease refractory to levodopa.…

Mea Holm, PhD
0
0

EAN 2019

https://www.ean.org/oslo2019/5th-Congress-of-the-European-Academy-of-Neurology-Oslo-2019.3649.0.html

https://www.brainwork.md/content/uploads/2018/11/Brainwork-Event-Oslo.jpg 5479 3653 Rachel Park, MA Rachel Park, MA https://secure.gravatar.com/avatar/4ebf9310e1faab0e0e0630445cf726cb?s=96&d=mm&r=g 12th November 2018 12th November 2018

2019 American Academy of Neurology Annual Meeting

https://www.brainwork.md/tag/aan/

https://www.brainwork.md/content/uploads/2018/11/Brainwork-Event-Philadelphia.jpg 4753 3168 Rachel Park, MA Rachel Park, MA https://secure.gravatar.com/avatar/4ebf9310e1faab0e0e0630445cf726cb?s=96&d=mm&r=g 12th November 2018 17th May 2019

2019 International Stroke Conference

http://isc2019.hawaiiconvention.com/

https://www.brainwork.md/content/uploads/2018/11/Brainwork-Event-Honolulu.jpg 3684 2763 Rachel Park, MA Rachel Park, MA https://secure.gravatar.com/avatar/4ebf9310e1faab0e0e0630445cf726cb?s=96&d=mm&r=g 12th November 2018 12th November 2018

American Epilepsy Society Annual Meeting

https://meeting.aesnet.org/

https://www.brainwork.md/content/uploads/2018/11/Brainwork-Event-New-Orleans.jpg 1919 1756 Rachel Park, MA Rachel Park, MA https://secure.gravatar.com/avatar/4ebf9310e1faab0e0e0630445cf726cb?s=96&d=mm&r=g 12th November 2018 12th November 2018

29th October 2018

Herpes and Alzheimer’s: Trigger or symptom?

https://www.brainwork.md/content/uploads/2018/10/Brainwork-Herpes.jpg 1920 1280 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 29th October 2018 29th October 2018

A new review article, published in Frontiers in Aging Neuroscience, has offered fresh evidence in support of a link between the Herpes Simplex Virus 1…

Peter Stevenson, PhD
0
0

19th October 2018

Cognitive impairment in MS

https://www.brainwork.md/content/uploads/2018/10/Brainwork-MSCognitive_2048-1.jpg 2048 1153 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 19th October 2018 1st February 2019

Up to 70% of MS patients suffer from cognitive decline, which often has a profound impact on an individual’s quality of life. It is little…

Mea Holm, PhD
0
0

16th October 2018

Serum neurofilament light: A biomarker for disease activity in MS

https://www.brainwork.md/content/uploads/2018/10/MPR425-Brainwork-illustration-soluble-biomarkers-V00-03-20181012.jpg 1920 1080 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 16th October 2018 19th October 2018

How close are we to establishing a reliable liquid biomarker for detecting disease onset, progression and treatment response in multiple sclerosis? According to Dr Peter…

Mea Holm, PhD
1
0

15th October 2018

Results from the MS-SMART trial unveiled

https://www.brainwork.md/content/uploads/2018/10/Brainwork-ECTRIMSSMART.jpg 3971 2975 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 15th October 2018 15th October 2018

Secondary progressive multiple sclerosis (SPMS) is known to be extremely difficult to treat; there are no effective therapies for halting or reversing disability progression in…

Mea Holm, PhD
0
0

15th October 2018

De-risking PML: A conversation with Prof. Walter Atwood

https://www.brainwork.md/content/uploads/2018/10/Brainwork-ECTRIMS-Outside.jpg 2872 2598 Prof. Dr. Krassen Nedeltchev Prof. Dr. Krassen Nedeltchev https://secure.gravatar.com/avatar/aaadc696c1b66fe476051e7e4012d01a?s=96&d=mm&r=g 15th October 2018 23rd October 2018

We interviewed Professor Walter Atwood last week at the 2018 ECTRIMS congress in Berlin, Germany, to learn about advances in treating progressive multifocal leukoencephalopathy (PML)…

Prof. Dr. Krassen Nedeltchev
0
1